• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Dips Over 500 Points; Nasdaq Down 2.5%

    12/6/22 2:36:30 PM ET
    $BNED
    $ENIC
    $GOSS
    $MEIP
    Other Specialty Stores
    Consumer Discretionary
    Electric Utilities: Central
    Utilities
    Get the next $BNED alert in real time by email

    U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 2.5% on Tuesday.

    The Dow traded down 1.50% to 33,436.64 while the NASDAQ fell 2.51% to 10,958.00. The S&P 500 also fell, dropping, 1.95% to 3,920.68.

    Also check this: Bitcoin Drops But Remains Above This Key Level; GMX Becomes Top Loser


    Leading and Lagging Sectors


    Utilities shares fell by just 0.4% on Tuesday. Meanwhile, top gainers in the sector included Enel Chile S.A. (NYSE:ENIC), up 7%, and ONE Gas, Inc. (NYSE:OGS), up 4%.


    In trading on Tuesday, energy shares dipped by 2.9%.


    Top Headline

     

    The US trade gap increased to a four-month high of $78.2 billion in October versus a revised gao of $74.1 billion in September. Exports from the US fell by $1.9 billion to $256.6 billion in October, while imports rose by $2.2 billion to $334.8 billion in October.

     


    Equities Trading UP

     

    • Vivint Smart Home, Inc. (NYSE:VVNT) shares shot up 32% to $11.90 after NRG Energy announced it will acquire the company for $12 per share in cash.
    • Shares of Signet Jewelers Limited (NYSE:SIG) got a boost, shooting 20% to $69.11 after the company reported better-than-expected Q3 results and issued FY23 guidance above estimates.
    • Summit Therapeutics Inc. (NASDAQ:SMMT) shares were also up, gaining 97% to $1.5450 after the company announced a definitive agreement of its partnership with Akeso to in-license its breakthrough bispecific antibody, ivonescimab.

     

    Equities Trading DOWN

    • Gossamer Bio, Inc. (NASDAQ:GOSS) shares tumbled 75% to $2.3691 after the company reported announced topline results for the TORREY Phase 2 study of seralutinib in patients with pulmonary arterial hypertension (PAH).
    • Shares of MEI Pharma, Inc. (NASDAQ:MEIP) were down 36% to $0.2512 after the company announced discontinuation of zandelisib development outside of Japan following a recent FDA meeting.
    • Barnes & Noble Education, Inc. (NYSE:BNED) was down, falling 35% to $1.6550 after reporting downbeat Q2 earnings.


    Also check out: Over $3 Million Bet On G-III Apparel? Check Out These 3 Stocks Insiders Are Buying


    Commodities

    In commodity news, oil traded down 4.3% to $73.62 while gold traded up 0.1% at $1,782.30.


    Silver traded down 0.5% to $22.315 on Tuesday while copper rose 0.4% to $3.81.

     


    Euro zone


    European shares closed lower today. The eurozone’s STOXX 600 fell 0.58%, London’s FTSE 100 fell 0.61% while Spain’s IBEX 35 Index fell 0.46%. The German DAX declined 0.72%, French CAC 40 fell 0.14% and Italy’s FTSE MIB Index fell 1.15%.

    The S&P Global construction PMI for the Eurozone dropped to 43.6 in November from 44.9 in the previous month, while French construction PMI declined to 40.7 in November from 44.3. The S&P Global German construction PMI declined to 41.5 from 43.8, while factory orders in Germany rose by 0.8% month-over-month during October.


    The S&P Global/CIPS construction PMI for the UK dropped to a three-month low of 50.4 for November, while retail sales in the country rose 4.1% year-over-year in November. The S&P Global Italy construction PMI rose to 52 in November from 48.1 in the previous month.

     

    Asia Pacific Markets


    Asian markets closed mixed on Tuesday, with the Japan’s Nikkei gaining 0.24% and Hong Kong’s Hang Seng Index dropping 0.40%. China’s Shanghai Composite Index rose 0.02%.

    Household spending in Japan increased by 1.2% from the previous year during October, while average cash earnings in the country climbed by 1.8% year-over-year in October.

    The Reserve Bank of Australia increased the cash rate by 25 bps to 3.1% at its recent meeting. Australia unexpectedly reported a current deficit of AUD 2.3 billion during Q3, versus market estimates of a AUD 6.2 billion surplus.

     

    Economics

     

    • The US trade gap increased to a four-month high of $78.2 billion in October versus a revised gao of $74.1 billion in September. Exports from the US fell by $1.9 billion to $256.6 billion in October, while imports rose by $2.2 billion to $334.8 billion in October.
    • The Logistics Manager’s Index declined for a second month to a reading of 53.6 in November from 57.5 in the previous month.

     

    Check out this: Investor Sentiment Drops Amid Concerns Over Further Fed Rate Increases


    COVID-19 Update

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 100,906,110 cases with around 1,106,990 deaths. India confirmed a total of at least 44,674,870 cases and 530,630 deaths, while France reported over 38,078,560 COVID-19 cases with 159,240 deaths. In total, there were at least 650,561,350 cases of COVID-19 worldwide with more than 6,648,270 deaths.

    Get the next $BNED alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BNED
    $ENIC
    $GOSS
    $MEIP

    CompanyDatePrice TargetRatingAnalyst
    Gossamer Bio Inc.
    $GOSS
    1/28/2026$9.00Overweight
    Barclays
    Summit Therapeutics Inc.
    $SMMT
    12/17/2025$18.00Underweight → Equal Weight
    Barclays
    Signet Jewelers Limited
    $SIG
    12/11/2025$96.00Neutral
    Goldman
    Signet Jewelers Limited
    $SIG
    12/3/2025$92.00 → $96.00Market Perform
    Telsey Advisory Group
    Summit Therapeutics Inc.
    $SMMT
    11/18/2025Peer Perform
    Wolfe Research
    ONE Gas Inc.
    $OGS
    11/18/2025$86.00Sell → Neutral
    UBS
    Signet Jewelers Limited
    $SIG
    11/11/2025$150.00Overweight
    Stephens
    ONE Gas Inc.
    $OGS
    9/26/2025$86.00Neutral → Outperform
    Mizuho
    More analyst ratings

    $BNED
    $ENIC
    $GOSS
    $MEIP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    Summit Therapeutics Inc. (NASDAQ:SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of up to 257,368 shares of common stock. Awards were made to 20 new employees of the Company. The awards were granted as an inducement material to the new employees becoming employees of the Company in accordance with Nasdaq Listing Rule 5635(c)(4) and have been approved by the Company's Compensation Committee. The inducement awards were granted on January 26, 2026. The options have a ten (10) year term and an exercise price of $16.56 per share, the closing price per share of the Company's common stock as reported by Nasdaq on Jan

    1/30/26 4:30:00 PM ET
    $SMMT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Summit Therapeutics Announces U.S. FDA Acceptance of Biologics License Application (BLA) Seeking Approval for Ivonescimab in Combination with Chemotherapy in Treatment of Patients with EGFRm NSCLC Post-TKI Therapy

    BLA Filing Based on HARMONi Global Phase III Study Results PDUFA Goal Action Date of November 14, 2026 Significant Unmet Need Remains; Over 14,000 U.S. Patients Eligible for Treatment Each Year in This Setting Summit Therapeutics Inc. (NASDAQ:SMMT) ("Summit," "we," or the "Company") today announced that the U.S. Food & Drug Administration (FDA) has accepted for filing Summit's Biologics License Application (BLA) seeking approval for ivonescimab in combination with chemotherapy in patients with epidermal growth factor receptor (EGFR)-mutated locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) post-tyrosine kinase inhibitor (TKI) therapy. The FDA provided a Pr

    1/29/26 7:30:00 AM ET
    $SMMT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ONE Gas Fourth Quarter and Year End 2025 Conference Call and Webcast Scheduled

    Schedule for 2026 Earnings News Releases, Conference Calls and Webcasts Also Announced  TULSA, Okla., Jan. 22, 2026 /PRNewswire/ -- ONE Gas, Inc. (NYSE:OGS) will release its fourth quarter and full year 2025 financial results after the market closes on Wednesday, Feb. 18, 2026. The ONE Gas executive management team will participate in a conference call the following day, Thursday, Feb. 19, 2026, at 11 a.m. Eastern Standard Time (10 a.m. Central Standard Time).  The call will also be carried live on the ONE Gas website. Event: ONE Gas fourth quarter and year end 2025 earnings

    1/22/26 4:15:00 PM ET
    $OGS
    Oil/Gas Transmission
    Utilities

    $BNED
    $ENIC
    $GOSS
    $MEIP
    SEC Filings

    View All

    SEC Form DEF 14A filed by Barnes & Noble Education Inc

    DEF 14A - Barnes & Noble Education, Inc. (0001634117) (Filer)

    2/3/26 3:05:03 PM ET
    $BNED
    Other Specialty Stores
    Consumer Discretionary

    Summit Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Summit Therapeutics Inc. (0001599298) (Filer)

    1/29/26 7:35:03 AM ET
    $SMMT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form S-3ASR filed by Gossamer Bio Inc.

    S-3ASR - Gossamer Bio, Inc. (0001728117) (Filer)

    1/28/26 4:01:24 PM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BNED
    $ENIC
    $GOSS
    $MEIP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Xia Yu bought $9,999,983 worth of shares (533,617 units at $18.74) (SEC Form 4)

    4 - Summit Therapeutics Inc. (0001599298) (Issuer)

    10/23/25 9:06:30 PM ET
    $SMMT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Co-Chief Executive Officer Duggan Robert W bought $499,983 worth of shares (26,680 units at $18.74) and was granted 14,247,597 shares, increasing direct ownership by 3% to 570,073,879 units (SEC Form 4)

    4 - Summit Therapeutics Inc. (0001599298) (Issuer)

    10/23/25 4:08:30 PM ET
    $SMMT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Co-Chief Executive Officer Zanganeh Mahkam was granted 14,247,597 shares and bought $499,983 worth of shares (26,680 units at $18.74) (SEC Form 4)

    4 - Summit Therapeutics Inc. (0001599298) (Issuer)

    10/23/25 4:06:32 PM ET
    $SMMT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BNED
    $ENIC
    $GOSS
    $MEIP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Sagi Raghunandan R was granted 5,405 shares (SEC Form 4)

    4 - SIGNET JEWELERS LTD (0000832988) (Issuer)

    1/14/26 6:02:37 PM ET
    $SIG
    Consumer Specialties
    Consumer Discretionary

    SEC Form 3 filed by new insider Sagi Raghunandan R

    3 - SIGNET JEWELERS LTD (0000832988) (Issuer)

    1/14/26 6:01:21 PM ET
    $SIG
    Consumer Specialties
    Consumer Discretionary

    SEC Form 4 filed by Chief Accounting Officer Anand Bhaskar

    4 - Summit Therapeutics Inc. (0001599298) (Issuer)

    1/12/26 4:01:39 PM ET
    $SMMT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BNED
    $ENIC
    $GOSS
    $MEIP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays initiated coverage on Gossamer Bio with a new price target

    Barclays initiated coverage of Gossamer Bio with a rating of Overweight and set a new price target of $9.00

    1/28/26 7:16:48 AM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Summit Therapeutics upgraded by Barclays with a new price target

    Barclays upgraded Summit Therapeutics from Underweight to Equal Weight and set a new price target of $18.00

    12/17/25 8:48:06 AM ET
    $SMMT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Goldman initiated coverage on Signet Jewelers with a new price target

    Goldman initiated coverage of Signet Jewelers with a rating of Neutral and set a new price target of $96.00

    12/11/25 9:14:03 AM ET
    $SIG
    Consumer Specialties
    Consumer Discretionary

    $BNED
    $ENIC
    $GOSS
    $MEIP
    Leadership Updates

    Live Leadership Updates

    View All

    ONE Gas Announces Retirement of Board Chair John Gibson and Election of Deborah Hersman as New Chair

    TULSA, Okla., Nov. 18, 2025 /PRNewswire/ -- ONE Gas, Inc. (NYSE:OGS) announced today that John W. Gibson, 73, will retire from the board and as chair after the Company's Annual Meeting for Shareholders next May. Mr. Gibson has served as chair since ONE Gas' inception in 2014. The board of directors has elected Deborah A.P. Hersman, 55, as chair of the Board, effective May 21, 2026, following a comprehensive succession planning process.   "I want to extend my heartfelt gratitude to John for his remarkable leadership and dedication over the past eleven years," said Robert S. McA

    11/18/25 4:15:00 PM ET
    $OGS
    Oil/Gas Transmission
    Utilities

    ONE Gas Announces Dual Listing on NYSE Texas

    TULSA, Okla., Nov. 10, 2025 /PRNewswire/ -- ONE Gas, Inc. (NYSE:OGS) today announced the dual listing of its common stock, effective Nov. 11, 2025, on NYSE Texas, a fully electronic equities exchange headquartered in Dallas, Texas. "Joining NYSE Texas is a natural step in our long-standing commitment to Texas, where we've invested, operated and built deep community ties for many decades. We believe this dual listing will broaden investor access and awareness of our mission to safely deliver affordable, reliable natural gas services to homes and businesses," said Robert S. McAn

    11/10/25 4:15:00 PM ET
    $OGS
    Oil/Gas Transmission
    Utilities

    ONE Gas Announces Retirement of General Counsel Joseph L. McCormick

    TULSA, Okla., July 1, 2025 /PRNewswire/ -- ONE Gas, Inc. (NYSE: OGS) announces the retirement of Joseph L. McCormick as senior vice president, general counsel and assistant corporate secretary, effective October 1, 2025. The ONE Gas Board of Directors has elected Regina L. Gregory to succeed McCormick as senior vice president, general counsel and assistant corporate secretary. McCormick has been an integral part of our management team for over 20 years, providing invaluable legal guidance and leadership. Before ONE Gas became a stand-alone, publicly traded company separate fro

    7/1/25 4:05:00 PM ET
    $OGS
    Oil/Gas Transmission
    Utilities

    $BNED
    $ENIC
    $GOSS
    $MEIP
    Financials

    Live finance-specific insights

    View All

    ONE Gas Fourth Quarter and Year End 2025 Conference Call and Webcast Scheduled

    Schedule for 2026 Earnings News Releases, Conference Calls and Webcasts Also Announced  TULSA, Okla., Jan. 22, 2026 /PRNewswire/ -- ONE Gas, Inc. (NYSE:OGS) will release its fourth quarter and full year 2025 financial results after the market closes on Wednesday, Feb. 18, 2026. The ONE Gas executive management team will participate in a conference call the following day, Thursday, Feb. 19, 2026, at 11 a.m. Eastern Standard Time (10 a.m. Central Standard Time).  The call will also be carried live on the ONE Gas website. Event: ONE Gas fourth quarter and year end 2025 earnings

    1/22/26 4:15:00 PM ET
    $OGS
    Oil/Gas Transmission
    Utilities

    ONE Gas Increases Quarterly Dividend

    TULSA, Okla., Jan. 20, 2026 /PRNewswire/ -- The board of directors of ONE Gas, Inc. (NYSE:OGS) today increased the dividend for the first quarter 2026 by 1 cent per share to 68 cents per share, resulting in an annualized dividend of $2.72 per share. The dividend is payable March 6, 2026, to shareholders of record at the close of business Feb. 20, 2026. The Company expects an average annual dividend increase of 1% to 2% through 2030, subject to approval by the board of directors. ONE Gas, Inc. (NYSE: OGS) is a 100% regulated natural gas utility, and trades on the New York Stock

    1/20/26 4:15:00 PM ET
    $OGS
    Oil/Gas Transmission
    Utilities

    Signet Jewelers Reports Third Quarter Fiscal 2026 Results

    Q3 Same Store Sales1 Growth of 3% Signet Jewelers Limited ("Signet" or the "Company") (NYSE:SIG) today announced its results for the 13 weeks ended November 1, 2025 ("third quarter Fiscal 2026"). "Signet's Grow Brand Love strategy delivered 3% same store sales growth led by Kay, Zales, and Jared which reflects our continued focus on our largest brands. Our balanced diamond assortment strategy, alongside ongoing stabilization in diamond retail prices, is driving growth and expanded average retails in both Bridal and Fashion," said J.K. Symancyk, Chief Executive Officer. "Looking forward, we believe we are well positioned for the holiday season with a focused assortment in key categories an

    12/2/25 6:50:00 AM ET
    $SIG
    Consumer Specialties
    Consumer Discretionary

    $BNED
    $ENIC
    $GOSS
    $MEIP
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Gossamer Bio Inc. on Jun 21

    Gossamer Bio Inc. recently witnessed an insider purchase by COO/CFO Bryan Giraudo, who acquired $59,110 worth of shares consisting of 100,000 units at $0.59 per share. Insider purchases like this can provide valuable insights for investors, indicating confidence from individuals within the company about its future prospects. Examining previous insider transactions, on 2024-03-19, insiders Peterson Caryn and Aranda Richard each sold $5,343 worth of shares at $1.33, leading to a decrease in their direct ownership percentages. Similarly, on 2024-03-28, Hasnain Faheem, Giraudo Bryan, and Christian Waage sold shares worth $26,773, $7,431, and $7,430, respectively, impacting their direct ownershi

    6/21/24 3:17:31 PM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BNED
    $ENIC
    $GOSS
    $MEIP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Barnes & Noble Education Inc

    SC 13G/A - Barnes & Noble Education, Inc. (0001634117) (Subject)

    11/14/24 6:34:18 PM ET
    $BNED
    Other Specialty Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Gossamer Bio Inc.

    SC 13G/A - Gossamer Bio, Inc. (0001728117) (Subject)

    11/12/24 4:40:26 PM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Gossamer Bio Inc.

    SC 13G/A - Gossamer Bio, Inc. (0001728117) (Subject)

    11/12/24 9:55:14 AM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care